9-Apr-2026
Business Wire (Wed, 8-Apr 4:15 PM ET)
Healthpeak Properties declares $0.1017 dividend
Seeking Alpha News (Mon, 6-Apr 4:19 PM ET)
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Second Quarter of 2026
Business Wire (Mon, 6-Apr 4:15 PM ET)
Globe Newswire (Tue, 24-Mar 10:00 AM ET)
Healthpeak Properties Closes New $400 Million Delayed-Draw Term Loan Facility
Business Wire (Mon, 23-Mar 4:16 PM ET)
Healthpeak Properties and Janus Living Announce Closing of Janus Living Initial Public Offering
Business Wire (Mon, 23-Mar 4:15 PM ET)
Business Wire (Thu, 19-Mar 4:35 PM ET)
Market Chameleon (Mon, 16-Mar 4:43 AM ET)
Healthpeak Properties and Janus Living Announce Launch of Janus Living Initial Public Offering
Business Wire (Mon, 16-Mar 6:44 AM ET)
Business Wire (Fri, 27-Feb 5:30 PM ET)
Healthpeak owns a diversified healthcare portfolio of approximately 700 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
Healthpeak Properties trades on the NYSE stock market under the symbol DOC.
As of April 9, 2026, DOC stock price climbed to $16.69 with 6,306,518 million shares trading.
DOC has a beta of 0.49, meaning it tends to be less sensitive to market movements. DOC has a correlation of 0.13 to the broad based SPY ETF.
DOC has a market cap of $11.60 billion. This is considered a Large Cap stock.
Last quarter Healthpeak Properties reported $719 million in Revenue and $.47 earnings per share. This beat revenue expectation by $26 million and exceeded earnings estimates by $.25.
In the last 3 years, DOC traded as high as $23.26 and as low as $10.52.
The top ETF exchange traded funds that DOC belongs to (by Net Assets): VNQ, VTI, VOO, VB, VBR.
DOC has underperformed the market in the last year with a price return of -0.4% while the SPY ETF gained +38.4%. However, in the short term, DOC had mixed performance relative to the market. It has outperformed in the last 3 months, returning -0.3% vs -1.1% return in SPY. But in the last 2 weeks, DOC shares have been beat by the market, returning -0.7% compared to an SPY return of +3.5%.
DOC support price is $16.37 and resistance is $16.99 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOC shares will trade within this expected range on the day.
